Medtronic Buys Lazarus Effect For 100 Million


Medtronic is acquiring private-held Lazarus Effect, developer of a mesh cover for stent retrievers of blood clots, for $100 million in cash. As part of the deal, Medtronic obtains the Lazarus Cover device, which will serve as an adjunct to Medtronic’s Solitaire stent retriever device, used to remove clots from acute ischemic stroke patients. A…

Read More

EU drugs agency recommends suspension of Medtronic implant

Europe’s medicines regulator has recommended the suspension of Medtronic Plc’s InductOs, an implant to help bone development, pending the resolution of issues at a U.S. plant where a sponge used in the implant is made. The European Medicines Agency (EMA) said it began a review of InductOs after an inspection in April by Dutch and…

Read More